Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
boston blog main
cancer
grail
life sciences
medicine
national blog main
andrew berens
avapritinib
bio
biotech
blueprint medicines
boston
cancer diagnostics
clinical trials
deciphera pharmaceuticals
economy
entrepreneurship
freenome
fundings & exits
gastrointestinal stromal tumor
gear
gist
gleevec
guardant health
health
ibm
ibmwatsonforoncology
imatinib
liquid biopsy
lucence
private equity
regorafenib
ripretinib
san francisco
san francisco blog main
san francisco top stories
science
startup company
startups
steve hoerter
What
cancer
5
×
plans
5
×
announced
company
medicine
screening
treatment
ability
algorithms
amazon
approval
area
based
bay
bezos
billion
biopsy
blood
blueprint
buildout
casts
chasing
city
close
come
conjure
costs
created
daniel
deadly
deal
decided
deciphera
developing
doesn’t
doubt
drug
early
effective
far
Language
unset
Current search:
plans
×
photo
×
cancer
×
@theverge.com
1 year ago
When healthcare is decided by algorithms, who wins?
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@engadget.com
5 years ago
IBM's Watson reportedly created unsafe cancer treatment plans
@techcrunch.com
7 years ago
Grail is raising at least $1 billion to fund its early cancer screening test